According to the research report titled ‘Anti-snoring Treatment Market Size By Type (Device {Mandible Advancement Devices, Tongue Stabilizing Devices, Nasal Devices, Continuous Positive Airway Pressure (CPAP) Devices, Chin straps}, Surgery {Uvulopalatopharyngoplasty , Tonsillectomy, Pillar Procedure, Radiofrequency Palatoplasty}), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, E-Commerce), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, India, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available at MarketStudyReport.com, the global anti-snoring treatment market is expected to reach USD 18 billion by the year 2025.
 

According to the report, growing occurrence of sleeping disorders such as periodic limb movement and sleep apnea is a major factor driving the anti-snoring treatment market growth. High pervasiveness of allergies and obesity and rising adoption of sedentary lifestyle is further aiding the market expansion
.

As per surgery, uvulopalatopharyngoplasty (UPPP) surgery segment is expected to exhibit a CAGR of 3.5% during the period of 2019-2025. The effects of uvulopalatopharyngoplasty surgery last for up to 36 months and hence this procedure is extensively used to treat snoring disorders. This factor in tandem with development of technologically advanced devices that can effectively manage snoring is stimulating the industry outlook.
 

In terms of distribution channel, the report cites that clinics segment held USD 2.4 billion in the year 2018 and is expected to register substantial growth during the forecast period. Easy availability of various types of oral anti-snoring devices and high accessibility of clinics are fueling the growth of the segment. Rising number of private clinics in developing nations are offering lucrative growth avenues for anti-snoring treatment market from clinics.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2144053/
 

As per the regional analysis, the report states that China accounted for 20% share of the Asia-Pacific anti-snoring treatment industry in the year 2018 and is anticipated to witness consistent growth in the forthcoming years. Growing geriatric population, increasing awareness pertaining to anti-snoring devices and rising adoption of technologically advanced devices and treatment methods are augmenting the demand of anti-snoring devices across the country.
 

Medtronic, Resmed, Fisher & Paykel Healthcare, GlaxoSmithKline Plc, Airway Management Inc., Meditas, SomnoMedc, Apnea Sciences Corp., The Pure Sleep Co., Philips Healthcare, Tomed Dr. Toussaint GmbH and Foundation Care (Theravent) are the prominent companies operating in the anti-snoring treatment market.